Fuller M - Search Results

1

Glycosaminoglycan fragments as a measure of disease burden in the mucopolysaccharidosis type I mouse.

Saville JT, McDermott BK, Fuller M. Saville JT, et al. Among authors: fuller m. Mol Genet Metab. 2018 Feb;123(2):112-117. doi: 10.1016/j.ymgme.2017.12.007. Epub 2017 Dec 13. Mol Genet Metab. 2018. PMID: 29273385

2

Recombinant canine alpha-l-fucosidase: expression, purification, and characterization.

Bielicki J, Muller V, Fuller M, Hopwood JJ, Anson DS. Bielicki J, et al. Among authors: fuller m. Mol Genet Metab. 2000 Jan;69(1):24-32. doi: 10.1006/mgme.1999.2947. Mol Genet Metab. 2000. PMID: 10655154

3

Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.

Fuller M, Meikle PJ, Hopwood JJ. Fuller M, et al. Glycobiology. 2004 May;14(5):443-50. doi: 10.1093/glycob/cwh049. Epub 2004 Jan 12. Glycobiology. 2004. PMID: 14718373

4

Determination of oligosaccharides and glycolipids in amniotic fluid by electrospray ionisation tandem mass spectrometry: in utero indicators of lysosomal storage diseases.

Ramsay SL, Maire I, Bindloss C, Fuller M, Whitfield PD, Piraud M, Hopwood JJ, Meikle PJ. Ramsay SL, et al. Among authors: fuller m. Mol Genet Metab. 2004 Nov;83(3):231-8. doi: 10.1016/j.ymgme.2004.07.015. Mol Genet Metab. 2004. PMID: 15542394

5

Prediction of neuropathology in mucopolysaccharidosis I patients.

Fuller M, Brooks DA, Evangelista M, Hein LK, Hopwood JJ, Meikle PJ. Fuller M, et al. Mol Genet Metab. 2005 Jan;84(1):18-24. doi: 10.1016/j.ymgme.2004.09.004. Mol Genet Metab. 2005. PMID: 15639191

6

Laronidase treatment of mucopolysaccharidosis I.

Wraith EJ, Hopwood JJ, Fuller M, Meikle PJ, Brooks DA. Wraith EJ, et al. Among authors: fuller m. BioDrugs. 2005;19(1):1-7. doi: 10.2165/00063030-200519010-00001. BioDrugs. 2005. PMID: 15691212 Review.

7

Validation of a heparan sulfate-derived disaccharide as a marker of accumulation in murine mucopolysaccharidosis type IIIA.

King B, Savas P, Fuller M, Hopwood J, Hemsley K. King B, et al. Among authors: fuller m. Mol Genet Metab. 2006 Feb;87(2):107-12. doi: 10.1016/j.ymgme.2005.09.026. Epub 2005 Dec 13. Mol Genet Metab. 2006. PMID: 16352454

8

Newborn screening for lysosomal storage disorders.

Meikle PJ, Grasby DJ, Dean CJ, Lang DL, Bockmann M, Whittle AM, Fietz MJ, Simonsen H, Fuller M, Brooks DA, Hopwood JJ. Meikle PJ, et al. Among authors: fuller m. Mol Genet Metab. 2006 Aug;88(4):307-14. doi: 10.1016/j.ymgme.2006.02.013. Epub 2006 Apr 4. Mol Genet Metab. 2006. PMID: 16600651

9

Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA.

Crawley AC, Gliddon BL, Auclair D, Brodie SL, Hirte C, King BM, Fuller M, Hemsley KM, Hopwood JJ. Crawley AC, et al. Among authors: fuller m. Brain Res. 2006 Aug 9;1104(1):1-17. doi: 10.1016/j.brainres.2006.05.079. Epub 2006 Jul 7. Brain Res. 2006. PMID: 16828069

10

Secondary sphingolipid accumulation in a macrophage model of Gaucher disease.

Hein LK, Meikle PJ, Hopwood JJ, Fuller M. Hein LK, et al. Among authors: fuller m. Mol Genet Metab. 2007 Dec;92(4):336-45. doi: 10.1016/j.ymgme.2007.08.001. Epub 2007 Sep 18. Mol Genet Metab. 2007. PMID: 17881272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,087 results

Search Page

Filters